Baird Upgrades DaVita HealthCare To Outperform

By: via Benzinga
Analysts at Baird upgraded DaVita HealthCare Partners Inc (NYSE: DVA) from Neutral to Outperform. The price target for DaVita ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.